Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 EUR | +2.78% | +4.35% | +125.35% |
04-12 | Nyxoah Names New Chief Medical Officer | MT |
04-12 | Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer | CI |
Sales 2024 * | 8.78M 9.39M 12.84M | Sales 2025 * | 36.18M 38.68M 52.88M | Capitalization | 275M 294M 402M |
---|---|---|---|---|---|
Net income 2024 * | -61M -65.22M -89.16M | Net income 2025 * | -69M -73.78M -101M | EV / Sales 2024 * | 25.3 x |
Net cash position 2024 * | 52.9M 56.56M 77.32M | Net Debt 2025 * | 16.5M 17.64M 24.12M | EV / Sales 2025 * | 8.07 x |
P/E ratio 2024 * |
-4.55
x | P/E ratio 2025 * |
-4.92
x | Employees | 147 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.79% |
Latest transcript on Nyxoah SA
1 day | +2.78% | ||
1 week | +4.35% | ||
Current month | -21.95% | ||
1 month | -22.27% | ||
3 months | +13.21% | ||
6 months | +63.82% | ||
Current year | +125.35% |
Managers | Title | Age | Since |
---|---|---|---|
Olivier Taelman
CEO | Chief Executive Officer | 54 | 19-06-30 |
Robert Taub
FOU | Founder | 78 | 09-07-14 |
Loïc Moreau
DFI | Director of Finance/CFO | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Rakin
BRD | Director/Board Member | 63 | 16-06-28 |
Robert Taub
FOU | Founder | 78 | 09-07-14 |
Jürgen Hambrecht
BRD | Director/Board Member | 77 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.6 | +2.78% | 17,475 |
24-04-25 | 9.34 | -4.69% | 8,309 |
24-04-24 | 9.8 | 0.00% | 12,036 |
24-04-23 | 9.8 | -2.49% | 33,253 |
24-04-22 | 10.05 | +9.24% | 54,904 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:37 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+125.35% | 294M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- NYXH Stock